Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

Cachexia is a syndrome characterized by involuntary weight loss and wasting of skeletal muscle mass. It is associated with worse overall survival and quality of life. The cancer-induced systemic inflammation and the consequent host derived catabolic stimuli, trigger cachexia by inhibiting muscle protein synthesis and enhancing muscle catabolism. The muscle itself may further promote chronic inflammation, introducing a vicious catabolic circle. Nutritional support alone plays a limited role in the treatment of cancer cachexia and should be combined with other interventions. Physical exercise lowers systemic inflammation and promotes muscle anabolism. It also attenuates the age-related physical decline in elderly and it might counteract the muscle wasting induced by the cancer cachexia syndrome. This review describes how cancer-induced systemic inflammation promotes muscle wasting and whether physical exercise may represent a suitable treatment for cancer-induced cachexia, particularly in patients with non-small cell lung cancer. We summarized pre-clinical and clinical studies investigating whether physical exercise would improve muscle performance and whether this improvement would translate in a clinically meaningful benefit for patients with cancer, in terms of survival and quality of life. Moreover, this review describes the results of studies investigating the interplay between physical exercise and the immune system, including the role of the intestinal microbiota.
Original languageEnglish
Pages (from-to)55-67
Number of pages13
JournalJournal of cachexia, sarcopenia and muscle
Volume13
Issue number1
Early online date10 Jan 2022
DOIs
Publication statusPublished - Feb 2022

Keywords

  • Cachexia
  • Systemic inflammation
  • Physical exercise
  • Immune system
  • Gut microbiota
  • SKELETAL-MUSCLE
  • CLINICAL-IMPLICATIONS
  • PROGNOSTIC-FACTOR
  • SARCOPENIA
  • IL-6
  • INTERLEUKIN-6
  • INFLAMMATION
  • MULTICENTER
  • ACTIVATION
  • STRENGTH

Cite this